Sangamo Therapeutics Inc (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,827 | -20,187 | -54,568 | -41,477 | -29,123 |
| Depreciation Amortization | -449 | 129 | 825 | 720 | 650 |
| Accounts receivable | -1,956 | -365 | 1,613 | 1,280 | 1,445 |
| Other Working Capital | 134,554 | -1,343 | 55,741 | 61,880 | 67,430 |
| Other Operating Activity | 8,985 | 3,632 | 7,568 | 5,618 | 3,306 |
| Operating Cash Flow | $104,307 | $-18,134 | $11,179 | $28,021 | $43,708 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -317,943 | -8,951 | -73,653 | -102,502 | -76,137 |
| PPE Investments | -5,768 | -2,616 | -3,751 | -2,873 | -2,175 |
| Investing Cash Flow | $-323,711 | $-11,567 | $-77,404 | $-105,375 | $-78,312 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 229,041 | 10,597 | 98,144 | 85,187 | 82,387 |
| Other Financing Activity | -57 | -14 | -654 | 0 | -7 |
| Financing Cash Flow | $228,984 | $10,583 | $97,490 | $85,187 | $82,380 |
| Beginning Cash Position | 53,326 | 53,326 | 22,061 | 22,061 | 22,061 |
| End Cash Position | 62,906 | 34,208 | 53,326 | 29,894 | 69,837 |
| Net Cash Flow | $9,580 | $-19,118 | $31,265 | $7,833 | $47,776 |
| Free Cash Flow | |||||
| Operating Cash Flow | 104,307 | -18,134 | 11,179 | 28,021 | 43,708 |
| Capital Expenditure | -5,768 | -2,616 | -3,751 | -2,873 | -2,175 |
| Free Cash Flow | 98,539 | -20,750 | 7,428 | 25,148 | 41,533 |